Growing company due to acquisitions, but different cultures need harmonisation
Analysis and evaluation of different therapeutic areas (neurology, gynecology, pulmonology, gastroenterology, immunology) and molecules for potential generic manufacturing and/or in-licensing. Preparation of medium and long-term forecasting for the company’s main therapeutic portfolios in close collaboration with the business development counterparts of the company’s foreign affiliates (Latvia, Lithuania, Russia, Turkey, Kazakhstan, Belorussia, Ukraine, Spain), the International Marketing Dept. Weighing of investment/return scenarios from development, marketing and sales perspectives. Continuous refreshing, update and adjustment of the product pipeline.
Czy ta opinia była pomocna?